15862185|t|Down syndrome, Alzheimer's disease and seizures.
15862185|a|Neuropathologically, Alzheimer-type abnormalities are demonstrated in patients with Down syndrome (DS), both demented and nondemented and more than a half of patients with DS above 50 years develop Alzheimer's disease (AD). The apolipoprotein E epsilon4 allele, oestrogen deficiency, high levels of Abeta1-42 peptide, elevated expression of BACE2, and valine polymorphism of prion protein gene are associated with earlier onset of dementia in DS individuals. Advanced AD alone may be an important risk factor for new-onset seizures in older adults and age above 60 years is a recognized risk factor for poor outcome from convulsive and nonconvulsive status epilepticus. DS patients aged over 45 years are significantly more likely to develop Alzheimer's disease than those less than 45 years and up to 84% demented individuals with DS develop seizures. Late-onset epilepsy in DS is associated with AD, while early-onset epilepsy is associated with an absence of dementia. In AD patients with a younger age of dementia onset are particularly susceptible to seizures. DS adults with epilepsy score significantly higher overall on the adaptive behaviour profile. Language function declined significantly more rapidly in AD patients with seizures and there is a good correlation between the severity of EEG abnormalities and cognitive impairment whereas in DS slowing of the dominant occipital rhythm is related to AD and the frequency of the dominant occipital activity decreases at the onset of cognitive deterioration.
15862185	0	13	Down syndrome	Disease	MESH:D004314
15862185	15	34	Alzheimer's disease	Disease	MESH:D000544
15862185	39	47	seizures	Disease	MESH:D012640
15862185	70	98	Alzheimer-type abnormalities	Disease	MESH:C536598
15862185	119	127	patients	Species	9606
15862185	133	146	Down syndrome	Disease	MESH:D004314
15862185	148	150	DS	Disease	MESH:D004314
15862185	158	166	demented	Disease	
15862185	207	215	patients	Species	9606
15862185	221	223	DS	Disease	MESH:D004314
15862185	247	266	Alzheimer's disease	Disease	MESH:D000544
15862185	268	270	AD	Disease	MESH:D000544
15862185	277	302	apolipoprotein E epsilon4	Gene	348
15862185	311	331	oestrogen deficiency	Disease	MESH:D007153
15862185	390	395	BACE2	Gene	25825
15862185	424	437	prion protein	Gene	5621
15862185	480	488	dementia	Disease	MESH:D003704
15862185	492	494	DS	Disease	MESH:D004314
15862185	517	519	AD	Disease	MESH:D000544
15862185	572	580	seizures	Disease	MESH:D012640
15862185	670	680	convulsive	Disease	MESH:D012640
15862185	685	717	nonconvulsive status epilepticus	Disease	MESH:D013226
15862185	719	721	DS	Disease	MESH:D004314
15862185	722	730	patients	Species	9606
15862185	791	810	Alzheimer's disease	Disease	MESH:D000544
15862185	855	863	demented	Disease	
15862185	881	883	DS	Disease	MESH:D004314
15862185	892	900	seizures	Disease	MESH:D012640
15862185	913	921	epilepsy	Disease	MESH:D004827
15862185	925	927	DS	Disease	MESH:D004314
15862185	947	949	AD	Disease	MESH:D000544
15862185	969	977	epilepsy	Disease	MESH:D004827
15862185	1011	1019	dementia	Disease	MESH:D003704
15862185	1024	1026	AD	Disease	MESH:D000544
15862185	1027	1035	patients	Species	9606
15862185	1058	1066	dementia	Disease	MESH:D003704
15862185	1105	1113	seizures	Disease	MESH:D012640
15862185	1115	1117	DS	Disease	MESH:D004314
15862185	1130	1138	epilepsy	Disease	MESH:D004827
15862185	1266	1268	AD	Disease	MESH:D000544
15862185	1269	1277	patients	Species	9606
15862185	1283	1291	seizures	Disease	MESH:D012640
15862185	1370	1390	cognitive impairment	Disease	MESH:D003072
15862185	1402	1404	DS	Disease	MESH:D004314
15862185	1460	1462	AD	Disease	MESH:D000544
15862185	1542	1565	cognitive deterioration	Disease	MESH:D003072
15862185	Association	MESH:D003704	348
15862185	Association	MESH:D003704	25825
15862185	Association	MESH:D003704	5621
15862185	Association	MESH:D004314	348
15862185	Association	MESH:D004314	5621
15862185	Association	MESH:D004314	25825

